Diagnostic and prognostic values of noninvasive predictors of portal hypertension in patients with alcoholic cirrhosis

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Cho, Eun Ju ^a   Kim, Moon Young ^b   Lee, Jeong Hoon ^a   Lee, Il Young ^b   Lim, Yoo Li ^b   Choi, Dae Hee ^c   Kim, Yoon Jun ^a   Yoon, Jung Hwan ^a   Baik, Soon Koo ^b  

^a Seoul National University   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; ESOPHAGUS VARICES; FEMALE; FIB 4; FOLLOW UP; FORN INDEX; HEPATIC VENOUS PRESSURE GRADIENT; HEPATOBILIARY PARAMETERS; HUMAN; LIVER STIFFNESS; LOK INDEX; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NON INVASIVE MEASUREMENT; OVERALL SURVIVAL; P2 MS; PLATELET COUNT TO SPLEEN DIAMETER RATIO; PORTAL HYPERTENSION; PROGNOSIS; PROGNOSTIC ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH VARICES; BLOOD; BLOOD ANALYSIS; BLOOD CELL; COMPLICATION; CYTOLOGY; FIBROSIS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MIDDLE AGED; PATHOLOGY; SPLEEN;

BIOLOGICAL MARKER;

ADULT; BIOMARKERS; BLOOD CELLS; BLOOD CHEMICAL ANALYSIS; FIBROSIS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; SPLEEN;

EID: 84941312589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133935     Document Type: Article

References (32)

1. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007; 133(2):481-8. doi:10.1053/j.gastro.2007.05.024PMID: 17681169.
2. de Franchis R, Baveno VF. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of hepatology. 2010; 53(4):762-8. doi:10.1016/j.jhep.2010.06.004 PMID: 20638742.
3. Shah V, Garcia-Cardena G, Sessa WC, Groszmann RJ. The hepatic circulation in health and disease: Report of a single-topic symposium. Hepatology. 1998; 27(1):279-88. doi:10.1002/hep.510270141 PMID: 9425948.
4. Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, Valla DC, et al. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Alimentary pharmacology & therapeutics. 2007; 26(3):359-68. doi:10.1111/j.1365-2036.2007.03378.x PMID: 17635370.
5. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007; 45 (5):1290-7. doi:10.1002/hep.21665 PMID: 17464971.
6. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Alimentary pharmacology & therapeutics. 2008; 28(9):1102-10. doi:10.1111/j.1365-2036.2008.03825.x PMID: 18691352.
7. Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. Journal of hepatology. 2011; 55(5):1017-24. doi:10.1016/j.jhep.2011.01.051 PMID: 21354450.
8. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of clinical epidemiology. 1992; 45(6):613-9. PMID: 1607900.
9. Kim MY, Suk KT, Baik SK, Kim HA, Kim YJ, Cha SH, et al. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology. 2012; 56(3):1053-62. doi:10.1002/hep.25752 PMID: 22473911.
10. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. The American journal of gastroenterology. 2010; 105(6):1382-90. doi:10.1038/ajg.2009.750 PMID: 20087336.
11. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound in medicine & biology. 2003; 29 (12):1705-13. PMID: 14698338.
12. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2):518-26. doi:10.1053/jhep.2003.50346 PMID: 12883497.
13. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36(4 Pt 1):986-92. doi:10.1053/jhep.2002.36128 PMID: 12297848.
14. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43 (6):1317-25. doi:10.1002/hep.21178 PMID: 16729309.
15. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology. 2005; 42(2):282-92. doi:10.1002/hep.20772 PMID: 15986415.
16. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003; 52(8):1200-5. PMID: 12865282; PubMed Central PMCID: PMC1773759.
17. Lee JH, Yoon JH, Lee CH, Myung SJ, Keam B, Kim BH, et al. Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients. Journal of viral hepatitis. 2009; 16(6):444-52. doi:10.1111/j.1365-2893.2009.01091.x PMID: 19200133.
18. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biometrical journal Biometrische Zeitschrift. 2005; 47(4):458-72. PMID: 16161804.
19. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, Practice Guidelines Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46(3):922-38. doi:10.1002/hep.21907 PMID: 17879356.
20. Saha P, Heagerty PJ. Time-dependent predictive accuracy in the presence of competing risks. Biometrics. 2010; 66(4):999-1011. doi:10.1111/j.1541-0420.2009.01375.x PMID: 20070296.
21. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statistics in medicine. 2011; 30(10):1105-17. doi:10.1002/sim.4154 PMID: 21484848; PubMed Central PMCID: PMC3079915.
22. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in medicine. 2011; 30(1):11-21. doi:10.1002/sim.4085 PMID: 21204120; PubMed Central PMCID: PMC3341973.
23. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013; 144(7):1426-37. e9. doi:10.1053/j.gastro.2013.02.042PMID: 23474284.
24. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014; 59(2):643-50. doi:10.1002/hep.26700PMID: 24038116.
25. Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, et al. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver international: official journal of the International Association for the Study of the Liver. 2010; 30(7):1073-81. doi:10.1111/j.1478-3231.2010.02269.xPMID: 20492510.
26. Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garcia-Pagan JC, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013; 144(1):102-11 e1. doi:10.1053/j.gastro.2012.10.001 PMID: 23058320.
27. Thabut D, Moreau R, Lebrec D. Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology. 2011; 53(2):683-94. doi:10.1002/hep.24129 PMID: 21274889.
28. Gelsi E, Dainese R, Truchi R, Marine-Barjoan E, Anty R, Autuori M, et al. Effect of detoxification on liver stiffness assessed by Fibroscan(R) in alcoholic patients. Alcoholism, clinical and experimental research. 2011; 35(3):566-70. doi:10.1111/j.1530-0277.2010.01374.x PMID: 21143253.
29. Girard DE, Kumar KL, McAfee JH. Hematologic effects of acute and chronic alcohol abuse. Hematology/oncology clinics of North America. 1987; 1(2):321-34. PMID: 3308825.
30. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, et al. Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology: The official clinical practice journal of the American Gastroenterological Association. 2013; 11(12):1573-84 e2. doi:10.1016/j.cgh.2013.07.034 PMID: 23954643.
31. Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, largescale study. Journal of hepatology. 2010; 53(4):630-8. doi:10.1016/j.jhep.2010.04.019PMID: 20615567.
32. Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol and alcoholism. 2004; 39(4):336-9. doi:10.1093/alcalc/agh074PMID: 15208167.